Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research Inc is a specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units, the Topical Products and Technology (TPT) Group and the Immunology Group.
Price: $4.22 Volume: 3,083
Change: $-0.12 % Change: -2.76%
Day High/Low: 4.34/4.22 52 Week High/Low: 10.36/2.50
Last Traded: March 26, 2015 11:44 Transaction Volume: 600
Open: 4.34 Previous Close: 4.34
Bid: 4.22 Ask: 4.26
Bid Size: 200 Ask Size: 300
Market Cap: 45.8m Shares Out: 10.9m
PE Ratio: 1.1 Dividend Yield: N/A

Opinion

More insiders buying Novo Research (T.NRI), Stockhouse poster says

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   December 19, 2014
0 stars

Leading growth stocks in the market today (BIIB) (ALXN) (AAPL)

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   March 26, 2014
0 stars

Nuvo Research's (T.NRI) shareholders react to latent FDA approval – stocks slip 21%

Gaalen Engen   January 17, 2014
0 stars

Junior energy stock pops on Pacific Rubiale investment

While gold/silver drill results grabbed the attention of some speculators Monday

Sean Mason   May 28, 2012
0 stars

Latest Bullboard Posts

  • Monday

    1 star

    If no proxy agenda by Monday, we will probably be halted for news..

    2 stars


  • RE:RE:Gud

    0 stars

    Gud is in a bubble- SELL. Sellers of NRI have dried up for the most part. I am now up 9% on NRI. It is very cheap now and there are many...

    3.5 stars


  • RE:Gud

    0 stars

    Almost no volume!! 131. Ominous???

    2 stars


  • Gud

    0 stars

    It has come $2 off its very recent highs. Is this possibly related to delay in AGM disclosure?

    2.5 stars


  • Current Market Sentiment

    0 stars

    States that NRI is a safe haven..... Believe it or not.

    3 stars